United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 100 mg in 5 ml - morphine sulfate oral solution is indicated for the management of acute and chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. morphine sulfate oral solution 100 mg per 5 ml (20 mg/ml) is indicated for the relief of acute and chronic pain in opioid-tolerant patients. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.2) ], reserve morphine sulfate oral solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: morphine sulfate oral solution is contraindicated in patients with: risk summary prolonged use of opioid analgesics during pregnancy can cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.5) ]. there are no available data with morphine sulfate oral solution in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. published s

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is contraindicated for: hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is also contraindicated in patients with: risk summary hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.13), clinical considerations ]. there are no available data with hydrocodone bitartrate, chlorpheniramine maleate and pseudo

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate and homatropine methylbromide oral solution is indicated for the symptomatic relief of cough in patients 18 years of age and older. important limitations of use : hydrocodone bitartrate and homatropine methylbromide oral solution is contraindicated for: hydrocodone bitartrate and homatropine methylbromide oral solution is also contraindicated in patients with: risk summary hydrocodone bitartrate and homatropine methylbromide oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.13), clinical considerations ]. there are no available data with hydrocodone bitartrate and homatropine methylbromide oral solution use in pregnant women to inform a drug-associated risk for adverse developmental outcomes. published studies with hydrocodone have reported inconsistent findings and have important methodological limitations (s

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of the anorectum, and pruritus ani. hydrocortisone acetate suppositories are contraindicated in those patients with a history of hypersensitivity to any of the components. drug abuse and dependence have not been reported in patients treated with hydrocortisone acetate suppositories.

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - ferrous sulfate (unii: 39r4tan1vt) (ferrous cation - unii:gw89581owr) - ferrous cation 65 mg

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - ferrous gluconate (unii: u1b11i423z) (ferrous cation - unii:gw89581owr) -

United States - English - NLM (National Library of Medicine)

paddock laboratories llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - isopropyl alcohol 500 mg in 1 ml - first aid antiseptic first aid to help prevent the risk of infection in: •minor cuts •scrapes •burns if you have deep or puncture wounds, animal bites or serious burns if condition persists or gets worse

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is an antidote for acetaminophen overdose indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen. overdose incidences are divided into two types; acute ingestion or repeated supratherapeutic ingestion (rsi). [see dosage and administration (2) and acetaminophen assays – interpretation and methodology-(acute or repeated supratherapeutic ingestion) (1.1, 1.2) ]. on admission for suspected acute acetaminophen overdose, a serum blood sample should be drawn at least 4 hours after ingestion to determine the acetaminophen level and will serve as a basis for determining the need for treatment with acetylcysteine. if the patient presents after 4 hours post-ingestion, the serum acetaminophen sample should be determined immediately. acetylcysteine injection should be administered within 8 hours from acetaminophen ingestion for maximal protection against hepatic injury for patients whose serum acetaminophen levels fall above the “possib

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - mineral oil (unii: t5l8t28fgp) (mineral oil - unii:t5l8t28fgp) - lubricant laxative for relief of occasional constipation (irregularity).  generally produces bowel movement in 6 to 8 hours. - if you have difficulty swallowing - in children under 6 years of age - if you are pregnant - for a period longer than week - if you are bedridden or aged - abdominal pain, nausea, or vomiting - noticed a sudden change in bowel habits that persists over a period of 2 weeks - presently taking a stool softener laxative - taking any other drug.  take this product 2 or more hours before or after other drugs.  laxatives may affect how other drugs work if you have rectal bleeding or failure to have a bowel movement after use.  these could be signs of a serious condition.

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - colistimethate sodium (unii: xw0e5ys77g) (colistimethate - unii:dl2r53p963) - colistin 150 mg in 2 ml